🇺🇸 FDA
Pipeline program

3ß-(4-methoxybenzyloxy)pregn-5-en-20-one

AEF0117-107

Phase 1 small_molecule terminated

Quick answer

3ß-(4-methoxybenzyloxy)pregn-5-en-20-one for Cannabis Abuse is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Cannabis Abuse
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials